11 Recruiting Platinum-Resistant Fallopian Tube Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Platinum-Resistant Fallopian Tube Carcinoma
Related Conditions
Top Recruiting Platinum-Resistant Fallopian Tube Carcinoma Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
📍 National Institutes of Health (NIH) — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔